Nanograb
AI-generated binders for targeted drug delivery
San Francisco, United States · Founded 2023 · $500K raised
- Headquarters
- San Francisco, California
- Employees
- 1–10
- Founded
- 2023
- Website
- nanograb.com
- Total Funding
- $500K
- Last Round
- $500K Venture RoundJun 2023
- Rounds
- 2
About
Nanograb is a computational drug discovery company that uses AI to generate the best combination of binders to treat different diseases. Our product allows drugs to be targeted to very specific areas of the body.
Summary
Nanograb is a Biotech company based in San Francisco, United States, founded in 2023. It has raised $500K in total across 2 rounds, most recently a $500K Venture Round round in Jun 2023. Investors include Sterling Road and Y Combinator Continuity Fund.
Tech & App Stack
3 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jun 2023
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
China's leading mRNA biotech company developing therapeutics for cancer and infectious diseases.
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
Late-stage biopharma using single-molecule tracking, AI, and engineering to discover and develop ...
Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...
Clinical-stage programmable cell therapy company developing engineered T-cell therapies for solid...